Literature DB >> 34927168

Cancer Stem Cells in Tumor Modeling: Challenges and Future Directions.

Elvan Dogan1, Asli Kisim2, Gizem Bati-Ayaz3, Gregory J Kubicek4, Devrim Pesen-Okvur5, Amir K Miri6.   

Abstract

Microfluidic tumors-on-chips models have revolutionized anticancer therapeutic research by creating an ideal microenvironment for cancer cells. The tumor microenvironment (TME) includes various cell types and cancer stem cells (CSCs), which are postulated to regulate the growth, invasion, and migratory behavior of tumor cells. In this review, the biological niches of the TME and cancer cell behavior focusing on the behavior of CSCs are summarized. Conventional cancer models such as three-dimensional cultures and organoid models are reviewed. Opportunities for the incorporation of CSCs with tumors-on-chips are then discussed for creating tumor invasion models. Such models will represent a paradigm shift in the cancer community by allowing oncologists and clinicians to predict better which cancer patients will benefit from chemotherapy treatments.

Entities:  

Keywords:  Cancer stem cells; microfluidics; tumor microenvironment; tumors-on-chips

Year:  2021        PMID: 34927168      PMCID: PMC8680587          DOI: 10.1002/anbr.202100017

Source DB:  PubMed          Journal:  Adv Nanobiomed Res        ISSN: 2699-9307


  139 in total

Review 1.  Microfluidics for cell-based high throughput screening platforms - A review.

Authors:  Guansheng Du; Qun Fang; Jaap M J den Toonder
Journal:  Anal Chim Acta       Date:  2015-11-22       Impact factor: 6.558

Review 2.  Three-dimensional (3D) culture in sarcoma research and the clinical significance.

Authors:  Songtao Gao; Jacson Shen; Francis Hornicek; Zhenfeng Duan
Journal:  Biofabrication       Date:  2017-08-03       Impact factor: 9.954

3.  Stage-Specific Human Induced Pluripotent Stem Cells Map the Progression of Myeloid Transformation to Transplantable Leukemia.

Authors:  Andriana G Kotini; Chan-Jung Chang; Arthur Chow; Han Yuan; Tzu-Chieh Ho; Tiansu Wang; Shailee Vora; Alexander Solovyov; Chrystel Husser; Malgorzata Olszewska; Julie Teruya-Feldstein; Deepak Perumal; Virginia M Klimek; Alexandros Spyridonidis; Raajit K Rampal; Lewis Silverman; E Premkumar Reddy; Elli Papaemmanuil; Samir Parekh; Benjamin D Greenbaum; Christina S Leslie; Michael G Kharas; Eirini P Papapetrou
Journal:  Cell Stem Cell       Date:  2017-02-16       Impact factor: 24.633

4.  Screening Therapeutic Agents Specific to Breast Cancer Stem Cells Using a Microfluidic Single-Cell Clone-Forming Inhibition Assay.

Authors:  Dongguo Lin; Peiwen Li; Jin Feng; Zhun Lin; Xiao Chen; Na Yang; Lihui Wang; Dayu Liu
Journal:  Small       Date:  2019-04-18       Impact factor: 13.281

Review 5.  Targeting cancer stem cells to suppress acquired chemotherapy resistance.

Authors:  S J Vidal; V Rodriguez-Bravo; M Galsky; C Cordon-Cardo; J Domingo-Domenech
Journal:  Oncogene       Date:  2013-10-07       Impact factor: 9.867

Review 6.  Functional Hydrogels With Tunable Structures and Properties for Tissue Engineering Applications.

Authors:  Xiaomeng Li; Qingqing Sun; Qian Li; Naoki Kawazoe; Guoping Chen
Journal:  Front Chem       Date:  2018-10-22       Impact factor: 5.221

Review 7.  Conversion of Stem Cells to Cancer Stem Cells: Undercurrent of Cancer Initiation.

Authors:  Said M Afify; Masaharu Seno
Journal:  Cancers (Basel)       Date:  2019-03-11       Impact factor: 6.639

8.  Ovarian cancer stem cells and macrophages reciprocally interact through the WNT pathway to promote pro-tumoral and malignant phenotypes in 3D engineered microenvironments.

Authors:  Shreya Raghavan; Pooja Mehta; Yuying Xie; Yu L Lei; Geeta Mehta
Journal:  J Immunother Cancer       Date:  2019-07-19       Impact factor: 13.751

9.  Comparison of two soft-agar methods for assaying chemosensitivity of human tumours in vitro: malignant melanomas.

Authors:  K M Tveit; L Endresen; H E Rugstad; O Fodstad; A Pihl
Journal:  Br J Cancer       Date:  1981-10       Impact factor: 7.640

10.  Hydrogel microfluidics for the patterning of pluripotent stem cells.

Authors:  S Cosson; M P Lutolf
Journal:  Sci Rep       Date:  2014-03-25       Impact factor: 4.379

View more
  1 in total

Review 1.  Insights into the Role of Gremlin-1, a Bone Morphogenic Protein Antagonist, in Cancer Initiation and Progression.

Authors:  Noha Mousaad Elemam; Abdullah Imadeddin Malek; Esraa Elaraby Mahmoud; Waseem El-Huneidi; Iman M Talaat
Journal:  Biomedicines       Date:  2022-01-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.